Cargando…

Prognostic value of the H(2)FPEF score in patients undergoing transcatheter aortic valve implantation

AIMS: The aim of this study was to assess the prognostic value of the H(2)FPEF score in patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) and preserved left ventricular ejection fraction (EF). METHODS AND RESULTS: In this multicentre study, a total of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ludwig, Sebastian, Pellegrini, Costanza, Gossling, Alina, Rheude, Tobias, Voigtländer, Lisa, Bhadra, Oliver D., Linder, Matthias, Kalbacher, Daniel, Koell, Benedikt, Waldschmidt, Lara, Schirmer, Johannes, Seiffert, Moritz, Reichenspurner, Hermann, Blankenberg, Stefan, Westermann, Dirk, Conradi, Lenard, Joner, Michael, Schofer, Niklas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835574/ https://www.ncbi.nlm.nih.gov/pubmed/33215870 http://dx.doi.org/10.1002/ehf2.13096

Ejemplares similares

Heyde syndrome: prevalence and outcomes in patients undergoing transcatheter aortic valve implantation
por: Waldschmidt, Lara, et al.
Publicado: (2021)

Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience
por: Westermann, Dirk, et al.
Publicado: (2021)

Correction to: Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience
por: Westermann, Dirk, et al.
Publicado: (2021)

Early results of a real-world series with two transapical transcatheter mitral valve replacement devices
por: Ludwig, S., et al.
Publicado: (2020)

End-stage renal disease, calcification patterns and clinical outcomes after TAVI
por: Grundmann, David, et al.
Publicado: (2021)

Valve-in-valve procedures for degenerated surgical and transcatheter aortic valve bioprostheses using a latest-generation self-expanding intra-annular transcatheter heart valve
por: Schaefer, Andreas, et al.
Publicado: (2023)

Temporal changes of patient characteristics over 12 years in a single-center transcatheter aortic valve implantation cohort
por: Demal, Till Joscha, et al.
Publicado: (2023)

TAVI for Pure Non-calcified Aortic Regurgitation Using a Self-Expandable Transcatheter Heart Valve
por: Schneeberger, Yvonne, et al.
Publicado: (2022)

Transcatheter aortic valve implantation in patients with a small aortic annulus: performance of supra-, intra- and infra-annular transcatheter heart valves
por: Voigtländer, Lisa, et al.
Publicado: (2021)

Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI
por: Grundmann, David, et al.
Publicado: (2023)

Repeat transcatheter aortic valve implantation using a latest generation balloon-expandable device for treatment of failing transcatheter heart valves
por: Schaefer, Andreas, et al.
Publicado: (2016)

Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation
por: Reichart, Daniel, et al.
Publicado: (2017)

Transcatheter Mitral Valve Repair in Surgical High-Risk Patients: Gender-Specific Acute and Long-Term Outcomes
por: Tigges, Eike, et al.
Publicado: (2016)

Prevention of LVOT Obstruction by Device-Mediated Laceration of the Anterior Mitral Valve Leaflet During TMVR
por: Ludwig, Sebastian, et al.
Publicado: (2023)

One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI
por: Ludwig, Sebastian, et al.
Publicado: (2022)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Comparison of latest generation supra-annular and intra-annular self-expanding transcatheter heart valves
por: Pellegrini, Costanza, et al.
Publicado: (2020)

Procedural volume and outcomes in patients undergoing VA-ECMO support
por: Becher, Peter Moritz, et al.
Publicado: (2020)

Seasonal trends of incidence and outcomes of cardiogenic shock : findings from a large, nationwide inpatients sample with 441,696 cases
por: Becher, Peter Moritz, et al.
Publicado: (2021)

The impact of extra-valvular cardiac damage on mid-term clinical outcome following transcatheter aortic valve replacement in patients with severe aortic stenosis
por: Pellegrini, Costanza, et al.
Publicado: (2022)

Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials
por: Pellegrini, Costanza, et al.
Publicado: (2020)

Early Outcomes of Endoscopic Papillary Muscle Relocation for Secondary Mitral Regurgitation Type IIIb in Patients With Severe Left Ventricular Dysfunction
por: Pausch, Jonas, et al.
Publicado: (2022)

Establishment of an enhanced recovery after surgery protocol in minimally invasive heart valve surgery
por: Kubitz, Jens C., et al.
Publicado: (2020)

Large Biatrial Thrombembolus Caught in Transit across a Patent Foramen Ovale
por: Schaefer, Andreas, et al.
Publicado: (2015)

A Novel Plug-Based Vascular Closure Device for Percutaneous Femoral Artery Closure in Patients Undergoing Minimally-Invasive Valve Surgery
por: Schaefer, Andreas, et al.
Publicado: (2021)

Secondary mitral regurgitation repair techniques and outcomes: Subannular repair techniques in secondary mitral regurgitation type IIIb
por: Pausch, Jonas, et al.
Publicado: (2021)

Prognostic impact of functional mitral regurgitation prior to left ventricular assist device implantation
por: Pausch, Jonas, et al.
Publicado: (2022)

Prognostic value of H(2)FPEF score in COVID-19
por: Patel, Priya, et al.
Publicado: (2022)

Association between diastolic stress test and H2FPEF score
por: Rendón-Giraldo, Jairo A., et al.
Publicado: (2022)

Applying the ESC 2016, H(2)FPEF, and HFA‐PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population
por: Nikorowitsch, Julius, et al.
Publicado: (2021)

Periprocedural Strategies for Stroke Prevention in Patients Undergoing Transcatheter Aortic Valve Implantation
por: Linder, Matthias, et al.
Publicado: (2022)

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement
por: Lachmann, Mark, et al.
Publicado: (2022)

Risk-related short-term clinical outcomes after transcatheter aortic valve implantation and their impact on early mortality: an analysis of claims-based data from Germany
por: Schofer, Niklas, et al.
Publicado: (2022)

Patient Characteristics, Treatment and Outcome in Non-Ischemic vs. Ischemic Cardiogenic Shock
por: Schrage, Benedikt, et al.
Publicado: (2020)

Spotlight on the SAPIEN 3 transcatheter heart valve
por: Rheude, Tobias, et al.
Publicado: (2018)

Predictive value of H(2)FPEF score in patients with heart failure with preserved ejection fraction
por: Sun, Yuxi, et al.
Publicado: (2021)

H(2)FPEF score predicts atherosclerosis presence in patients with systemic connective tissue disease
por: Vasilev, Vladimir, et al.
Publicado: (2021)

Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock
por: Schrage, Benedikt, et al.
Publicado: (2021)

H(2)FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors
por: Suzuki, Satoru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ltp4vf398ge55arv4rih2pgrs9